Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer.

Qiu JJ, Guo JJ, Lv TJ, Jin HY, Ding JX, Feng WW, Zhang Y, Hua KQ.

Tumour Biol. 2013 Oct;34(5):2971-5. doi: 10.1007/s13277-013-0860-6. Epub 2013 May 28.

PMID:
23712606
2.

Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.

Guo F, Feng L, Hu JL, Wang ML, Luo P, Zhong XM, Deng AM.

Tumour Biol. 2015 Jan;36(1):453-8. doi: 10.1007/s13277-014-2662-x. Epub 2014 Oct 1.

PMID:
25270739
3.

Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.

Zhang J, Tang L, Chen Y, Duan Z, Xiao L, Li W, Liu X, Shen L.

Hum Pathol. 2015 Sep;46(9):1331-40. doi: 10.1016/j.humpath.2015.05.015. Epub 2015 May 30.

PMID:
26193797
4.

CIAPIN1 nuclear accumulation predicts poor clinical outcome in epithelial ovarian cancer.

Cai X, Wang J, Xin X.

World J Surg Oncol. 2012 Jun 19;10:112. doi: 10.1186/1477-7819-10-112.

5.

Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.

Hou T, Yang C, Tong C, Zhang H, Xiao J, Li J.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):280-7. eCollection 2014.

6.

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.

Li T, Xue H, Guo Y, Guo K.

Oncol Rep. 2014 Apr;31(4):1825-31. doi: 10.3892/or.2014.3045. Epub 2014 Feb 20.

PMID:
24573179
7.

Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.

Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y.

Med Oncol. 2013 Mar;30(1):324. doi: 10.1007/s12032-012-0324-7. Epub 2012 Dec 18.

PMID:
23254963
8.

The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Jiang L, Liu R, Wang Y, Li C, Xi Q, Zhong J, Liu J, Yang S, Wang J, Huang M, Tang C, Fang Z.

J Mol Histol. 2015 Jun;46(3):291-302. doi: 10.1007/s10735-015-9622-7. Epub 2015 May 17.

PMID:
25981880
9.

Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.

Peng DX, Luo M, Qiu LW, He YL, Wang XF.

Oncol Rep. 2012 Apr;27(4):1238-44. doi: 10.3892/or.2012.1625. Epub 2012 Jan 11.

10.

Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.

Cao JY, Liu L, Chen SP, Zhang X, Mi YJ, Liu ZG, Li MZ, Zhang H, Qian CN, Shao JY, Fu LW, Xia YF, Zeng MS.

Mol Cancer. 2010 Sep 9;9:237. doi: 10.1186/1476-4598-9-237.

11.

Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).

Shuang T, Wang M, Zhou Y, Shi C.

Med Oncol. 2015 Dec;32(12):260. doi: 10.1007/s12032-015-0706-8. Epub 2015 Oct 31.

PMID:
26520143
12.

Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.

Xu N, Zhang Z, Zhu J, Xu L, Li Y, Duan L, Mao Y, Li H.

Int J Exp Pathol. 2016 Apr;97(2):150-8. doi: 10.1111/iep.12174. Epub 2016 Apr 29.

13.

KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.

Huang L, Wang HY, Li JD, Wang JH, Zhou Y, Luo RZ, Yun JP, Zhang Y, Jia WH, Zheng M.

Cell Death Dis. 2013 Aug 1;4:e745. doi: 10.1038/cddis.2013.256.

14.
15.

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.

Sun F, Ding W, He JH, Wang XJ, Ma ZB, Li YF.

BMC Cancer. 2015 Oct 20;15:746. doi: 10.1186/s12885-015-1723-x.

16.

Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.

Lv Q, Sun H, Cao C, Gao B, Qi Y.

Tumour Biol. 2016 Feb;37(2):2721-7. doi: 10.1007/s13277-015-4112-9. Epub 2015 Sep 25.

PMID:
26408177
17.

Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.

Zhang W, Niu C, He W, Hou T, Sun X, Xu L, Zhang Y.

Tumour Biol. 2016 May;37(5):6239-54. doi: 10.1007/s13277-015-4419-6. Epub 2015 Nov 28.

18.

Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.

Leng R, Liao G, Wang H, Kuang J, Tang L.

Med Oncol. 2015 Feb;32(2):329. doi: 10.1007/s12032-014-0329-5. Epub 2015 Jan 14.

PMID:
25585684
19.

Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.

Ma M, Yu N.

Tohoku J Exp Med. 2017 Mar;241(3):239-247. doi: 10.1620/tjem.241.239.

20.

NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.

Wang H, Mu X, Zhou S, Zhang J, Dai J, Tang L, Xiao L, Duan Z, Jia L, Chen S.

Hum Pathol. 2014 Feb;45(2):401-8. doi: 10.1016/j.humpath.2013.10.005. Epub 2013 Oct 19.

PMID:
24439227

Supplemental Content

Support Center